Skip to main content
SpringerLink
Log in

Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by thrombosis and/or recurrent fetal loss as well as the presence of autoantibodies against epitopes present on phospholipid-binding proteins. The role of cellular immunity in the pathogenesis of the syndrome remains unclear. We studied the cellular phenotype and the production of type 1 [interferon (IFN)-γ, interleukin (IL)-2] and type 2 (IL-4, IL-10) cytokines by CD4+ and CD8+ T-lymphocyte subsets in 13 patients with untreated primary APS (PAPS) and in 32 healthy controls. The production of cytokines was determined in T cells after a 5-h culture with or without mitogenic stimulation using a flow cytometric method of intracellular cytokine staining. In six of the patients these studies were repeated 6 months later. In PAPS patients we found a reduced percentage of circulating CD4+CD45RA+ and an increased percentage and absolute number of CD8+HLA-DR+ cells. A type 1 response was observed in the patients’ unstimulated cells, indicated by an increase in IFN-γ-producing CD8+, IL-2-producing CD4+ T cells, and a decrease in IL-4-producing CD4+ and CD8+ T cells. Similar results were obtained in the patients at follow-up. Taken together, these results suggest a chronic in vivo stimulation of CD4+ and CD8+ T cells in PAPS patients exhibiting a type 1 polarization. Changes of cellular immunity may contribute to the pathogenesis of the clinical manifestations of the syndrome and might be proven to be useful targets for therapeutic interventions in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Abe K, Takasaki Y, Ushiyama C, Asakawa J, Fukazawa T, Seki M, Hirashima M, Ogaki M, Hashimoto HL (1999) Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus. J Clin Immunol 19:58–66

    Article  CAS  PubMed  Google Scholar 

  2. van Aken BE, Reitsman PH, Rosendaal FR (2002) Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 116:173–177

    Article  PubMed  Google Scholar 

  3. Amel-Kashipaz MR, Huggins ML, Lanyon P, Robins A, Todd I, Powell RJ (2001) Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8− and CD8+ T cells in systemic lupus erythematosus. J Autoimmun 17:155–163

    Article  CAS  PubMed  Google Scholar 

  4. Amengual O, Atsumi T, Khamashta MA, Hughes GR (1998) The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 79:276–281

    CAS  PubMed  Google Scholar 

  5. Arai T, Yoshida K, Kaburaki J, Inoko H, Ikeda Y, Kawakami Y, Kuwana M (2001) Autoreactive CD4+ T-cell clones to β2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site. Blood 98:1889–1896

    Article  CAS  PubMed  Google Scholar 

  6. Blank M, Tomer Y, Slavin S, Shoenfeld Y (1995) Induction of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation. Scand J Immunol 42:226–234

    CAS  PubMed  Google Scholar 

  7. Crispin JC, Martinez A, de Pablo P, Vellasquillo C, Alcocer-Varela J (1998) Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus. Scand J Immunol 48:196–200

    Article  CAS  PubMed  Google Scholar 

  8. Del Prete G, De Carli M, Lammel RM, D’Elios MM, Daniel KC, Giusti B, Abbate R, Romagnani S (1995) Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 86:250–257

    CAS  PubMed  Google Scholar 

  9. Dobado-Berrios PM, Lopez-Pedrera C, Velasco F, Cuadrado MJ (2001) The role of tissue factor in the antiphospholipid syndrome. Arthritis Rheum 44:2467–2476

    Article  CAS  PubMed  Google Scholar 

  10. Edwards RL, Rickles FR (1992) The role of leucocytes in the activation of blood coagulation. Semin Hematol 29:202–212

    CAS  PubMed  Google Scholar 

  11. Esmon CT (2003) Inflammation and thrombosis. J Thromb Haemost 1:1343–1348

    Article  CAS  PubMed  Google Scholar 

  12. Gordon C, Matthews N, Schlesinger BC, Akbar AN, Bacon PA, Emery P, Salmon M (1996) Active systemic lupus erythematosus is associated with the recruitment of naïve/resting T cells. Br J Rheumatol 35:226–230

    CAS  PubMed  Google Scholar 

  13. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 109:704–715

    Article  CAS  PubMed  Google Scholar 

  14. Hattori N, Kuwana M, Kaburaki J, Mimori T, Ikeda Y, Kawakami Y (2000) T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum 43:65–75

    Article  CAS  PubMed  Google Scholar 

  15. Hennesy B, North J, Deru A, Llewellyn-Smith N, Lowdell MW (2001) Use of Leu3a/3b for the accurate determination of CD4 subsets for measurement of intracellular cytokines. Cytometry 44:148–152

    Article  PubMed  Google Scholar 

  16. Hill JA, Choi BC (2000) Maternal immunological aspects of pregnancy success and failure. J Reprod Fertil Suppl 55:91–97

    CAS  PubMed  Google Scholar 

  17. Ito H, Marsushita S, Tokano Y, Nishimura H, Tanaka Y, Fujisao S, Mitsuya H, Hashimoto H, Nishimura Y (2000) Analysis of T cell responses to the β2-glycoprotein I-derived peptide library in patients with anti-β2-glycoprotein I antibody-associated autoimmunity. Hum Immunol 61:366–377

    Article  CAS  PubMed  Google Scholar 

  18. Kantor AB (1991) The development and repertoire of B-1 cells (CD5 Bcells). Immunol Today 12:389–391

    Article  CAS  PubMed  Google Scholar 

  19. Kornberg A, Blank M, Kaufman S, Shoenfeld Y (1994) Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol 153:1328–1332

    Google Scholar 

  20. Krause I, Blank M, Levi Y, Koike T, Barak V, Shoenfeld Y (1999) Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression. Clin Exp Immunol 117:190–197

    Article  CAS  PubMed  Google Scholar 

  21. Kuwana M (2003) Autoreactive CD4(+) T cells to beta(2)-glycoprotein I in patients with antiphospholipid syndrome. Autoimmun Rev 2:192–198

    Article  CAS  PubMed  Google Scholar 

  22. Maeda N, Sekigawa I, Iida N, Matsumoto M, Hashimoto H, Hirose S (1999) Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus. Scand J Rheumatol 28:166–170

    Article  CAS  PubMed  Google Scholar 

  23. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, Maino VC (1995) Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86:1408–1419

    CAS  PubMed  Google Scholar 

  24. Piette JC, Wechsler B, Frances C, Papo T, Godeau P (1993) Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 20:1802–1804

    CAS  PubMed  Google Scholar 

  25. Price BE, Rauch J, Shia MA, Walsh MT, Lieberthal W, Gilligan HM, O’Laughlin T, Koh JS, Levine JS (1996) Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a β2-glycoprotein I-dependent manner. J Immunol 157:2201–2208

    CAS  PubMed  Google Scholar 

  26. Prussin C, Metcalfe DD (1995) Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 188:117–128

    Article  CAS  PubMed  Google Scholar 

  27. Rauch J, Subang R, D’Agnillo P, Koh JS, Levine JS (2000) Apoptosis and the antiphospholipid syndrome. J Autoimmun 15:231–235

    Article  CAS  PubMed  Google Scholar 

  28. Risso A, Smilovich D, Capra MC, Baldissarro I, Yan G, Bargellesi A, Cosulich ME (1991) CD69 in resting and activated T lymphocytes. Its association with a GPT binding protein and biochemical requirements for its expression. J Immunol 146:4105–4114

    CAS  PubMed  Google Scholar 

  29. Souza SS, Ferriani RA, Santos CM, Voltarelli JC (2002) Immunological evaluation of patients with recurrent abortion. J Reprod Immunol 56:111–121

    Article  CAS  PubMed  Google Scholar 

  30. Villiard JF, Bloch-Michel C, Neau-Cransac M, Taupin JL, Miossec GV, Mercie P, Pellegrin JL, Moreau JF (2001) HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus. Clin Exp Immunol 125:485–491

    Article  PubMed  Google Scholar 

  31. Visvanathan S, McNeil HP (1999) Cellular immunity to β2-glycoprotein-1 in patients with the antiphospholipid syndrome. J Immunol 162:6919–6925

    CAS  PubMed  Google Scholar 

  32. Visvanathan S, Geczy CL, Harmer JA, McNeil HP (2000) Monocyte tissue factor induction by activation of β2-glycoprotein-I-specific T lymphocytes is associated with thrombosis and fetal loss in patients with antiphospholipid antibodies. J Immunol 165:2258–2262

    CAS  PubMed  Google Scholar 

  33. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Ware Branch D, Piette JC, Brey R, Derksen R, Nigel Harris E, Hughes GRV, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 42:1309–1311

    Article  CAS  PubMed  Google Scholar 

  34. Yoshida K, Arai T, Kaburaki J, Ikeda Y, Kawakami Y, Kuwana M (2002) Restricted T-cell receptor β-chain usage by T cells autoreactive to β2-glycoprotein I in patients with antiphospholipid syndrome. Blood 99:2499–2504

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Hellenic Rheumatology Society.

Author information

Authors and Affiliations

  1. Laboratory Hematology and Transfusion Medicine, School of Medicine, University of Patras, Patras, 26110, Greece

    Marina Karakantza, Georgios L. Theodorou, Athanasia Mouzaki & Alice Maniatis

  2. Rheumatology Unit, School of Medicine, University of Patras, Patras, Greece

    Nikolaos Meimaris & Andrew P. Andonopoulos

  3. Department of Neurology, School of Medicine, University of Patras, Patras, Greece

    Ellul John

Authors
  1. Marina Karakantza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Georgios L. Theodorou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nikolaos Meimaris
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Athanasia Mouzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ellul John
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrew P. Andonopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alice Maniatis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marina Karakantza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karakantza, M., Theodorou, G.L., Meimaris, N. et al. Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome. Ann Hematol 83, 704–711 (2004). https://doi.org/10.1007/s00277-004-0910-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-004-0910-7

Keywords

Search

Navigation